An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children

@inproceedings{Nair2011AnEO,
  title={An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children},
  author={H. Vinayak Nair and Vasundhara R Verma and Evropi Theodoratou and Lina Zgaga and Tanvir M Huda and EricA. F. Simoes and Peter Farnum Wright and Igor Rudan and H. Eloise Campbell},
  booktitle={BMC public health},
  year={2011}
}
BACKGROUND Respiratory Syncytial Virus (RSV) is the leading cause of acute lower respiratory infections (ALRI) in children. It is estimated to cause approximately 33.8 million new episodes of ALRI in children annually, 96% of these occurring in developing countries. It is also estimated to result in about 53,000 to 199,000 deaths annually in young children. Currently there are several vaccine and immunoprophylaxis candidates against RSV in the developmental phase targeting active and passive… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 1 time. VIEW TWEETS

Citations

Publications citing this paper.
SHOWING 1-10 OF 27 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 79 REFERENCES

Edinburgh Flu Study Group: Global incidence of severe acute lower respiratory infections due to seasonal influenza in young children: a systematic review and meta-analyses

  • H Nair, H Campbell
  • International Conference on Emerging Infectious…
  • 2010
1 Excerpt

Respiratory syncytial virus

  • S Storey
  • market. Nat Rev Drug Discov
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…